CCL11 (also known as Eotaxin-1) is a secreted CC chemokine that functions as a potent and selective chemoattractant for eosinophils. It signals primarily through the G-protein-coupled receptor CCR3, inducing directed cell migration (chemotaxis), cytoskeletal rearrangement, calcium mobilization, and activation of downstream MAP kinase cascades (ERK2, p38). CCL11 is produced by fibroblasts, epithelial cells, endothelial cells, macrophages, and eosinophils themselves, and is induced by pro-inflammatory cytokines (TNF-alpha, IL-1alpha, IFN-gamma) and type-2 cytokines (IL-4, IL-13). Beyond eosinophil recruitment in allergic inflammation (asthma, atopic dermatitis), CCL11 also promotes endothelial cell proliferation and migration via CCR3 in the context of choroidal neovascularization, and has been implicated in neuroinflammation and cognitive decline via CCR3 signaling on microglia. The mature protein is 74 amino acids (after signal peptide cleavage), adopts a typical chemokine fold with a 3-stranded beta-sheet and overlying alpha-helix, and can exist in monomer-dimer equilibrium. It is O-glycosylated at Thr-94.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CCL11/Eotaxin is a secreted chemokine that functions in the extracellular space. UniProt annotates it as "Secreted" (PubMed:8597956). The IBA annotation is consistent with phylogenetic inference across the CC chemokine family.
Reason: CCL11 is a secreted protein that acts extracellularly to create chemotactic gradients. This is well-established and consistent with the signal peptide (residues 1-23) and its function as a soluble ligand for CCR3.
Supporting Evidence:
PMID:8597956
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.
|
|
GO:0008009
chemokine activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Chemokine activity is the core molecular function of CCL11. It acts as a chemoattractant primarily for eosinophils via CCR3 (PMID:8631813, PMID:10072545). The IBA annotation is phylogenetically sound across CC chemokines.
Reason: CCL11 is definitively a chemokine. Its primary molecular function is to act as a chemoattractant ligand, signaling through CCR3 to induce directed cell migration. This is its canonical and core function.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
|
|
GO:0070098
chemokine-mediated signaling pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CCL11 is a chemokine ligand that initiates chemokine-mediated signaling through CCR3. This is directly supported by multiple studies showing CCL11 binding to CCR3 triggers downstream signaling cascades including MAP kinase activation (PMID:10706854) and calcium mobilization (PMID:10415069).
Reason: As a chemokine, CCL11 inherently participates in chemokine-mediated signaling pathways by binding and activating its receptor CCR3. This is a core function.
Supporting Evidence:
PMID:10706854
Eotaxin and other CC chemokines acting via CC chemokine receptor-3 (CCR3) are believed to play an integral role in the development of eosinophilic inflammation in asthma and allergic inflammatory diseases.
|
|
GO:0061844
antimicrobial humoral immune response mediated by antimicrobial peptide
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: This IBA annotation is propagated from the broader CC chemokine family. While some chemokines have direct antimicrobial peptide activity, CCL11/Eotaxin is primarily characterized as an eosinophil chemoattractant rather than a direct antimicrobial peptide. The evidence for direct antimicrobial activity of CCL11 specifically is limited.
Reason: While the IBA annotation reflects a phylogenetically-inferred function shared across CC chemokines, CCL11 is not primarily known for direct antimicrobial peptide activity. Its core function is eosinophil chemotaxis. Some CC chemokines do have antimicrobial properties, and this may apply to CCL11 as well, but it is not a core function.
|
|
GO:0048245
eosinophil chemotaxis
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Eosinophil chemotaxis is the canonical and best-characterized biological process of CCL11/Eotaxin. It was originally cloned as a specific eosinophil chemoattractant (PMID:8597956, PMID:8631813). The IBA annotation reinforces this across species.
Reason: This is arguably the single most defining function of CCL11. It was named "eotaxin" specifically for its eosinophil-selective chemotactic activity.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
|
|
GO:0030335
positive regulation of cell migration
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CCL11 promotes cell migration in multiple cell types. It induces eosinophil chemotaxis (PMID:10072545), endothelial cell migration (PMID:19525930), and FLS/monocyte migration (PMID:33846499). The IBA annotation is well-supported.
Reason: As a chemokine, positive regulation of cell migration is a core function of CCL11. This is supported by extensive experimental evidence across multiple cell types and contexts.
Supporting Evidence:
PMID:19525930
All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f).
|
|
GO:0006954
inflammatory response
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CCL11 is a pro-inflammatory chemokine that plays a central role in allergic inflammatory responses by recruiting eosinophils to sites of inflammation. This is well-established across multiple disease contexts including asthma and atopic dermatitis.
Reason: Involvement in inflammatory response is a core function of CCL11. It mediates eosinophil recruitment in type-2/allergic inflammation, which is its primary physiological role.
Supporting Evidence:
PMID:10708591
Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3.
|
|
GO:0048020
CCR chemokine receptor binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CCL11 binds CCR3 as its primary receptor (PMID:8631813). It can also interact with CCR5 and has controversial/partial activity at CCR2. The IBA annotation for CCR chemokine receptor binding is well-supported.
Reason: CCR chemokine receptor binding is a core molecular function of CCL11. It binds CCR3 with high affinity as its principal receptor. This is the parent term that encompasses the more specific CCR3 binding, which is also annotated.
Supporting Evidence:
PMID:9712872
The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy.
|
|
GO:0005125
cytokine activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: CCL11 is classified as a cytokine (specifically a chemokine, which is a subclass of cytokines). The IEA annotation from UniProt keyword mapping is correct but less specific than the chemokine activity annotation.
Reason: Cytokine activity is a parent term of chemokine activity. While less specific, it is not incorrect. The more specific chemokine activity term is also present. Acceptable as a broader IEA annotation.
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: CCL11 is a secreted protein that localizes to the extracellular region. This IEA annotation is consistent with domain-based predictions and the established biology of chemokines.
Reason: Extracellular region is a broader parent of extracellular space. Both are correct for this secreted chemokine. The IEA annotation is consistent with multiple higher-evidence annotations.
|
|
GO:0005615
extracellular space
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Duplicate of the IBA annotation for the same term. CCL11 is secreted and acts in the extracellular space. This IEA annotation is redundant with the IBA annotation but not incorrect.
Reason: Correct localization for a secreted chemokine. Redundant with IBA but acceptable as independent evidence.
|
|
GO:0006935
chemotaxis
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: CCL11 is a chemotactic factor. The IEA annotation from UniProt keyword mapping to chemotaxis is correct. More specific terms (eosinophil chemotaxis) are also annotated.
Reason: Chemotaxis is a core biological process for CCL11. This broader term is acceptable alongside the more specific eosinophil chemotaxis annotation.
|
|
GO:0006954
inflammatory response
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: Duplicate of the IBA annotation for inflammatory response. CCL11 is clearly involved in inflammatory responses. The IEA from keyword mapping is redundant but correct.
Reason: Correct annotation, redundant with IBA annotation for the same term.
|
|
GO:0006955
immune response
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: CCL11 participates in immune responses by recruiting eosinophils and other immune cells. The IEA annotation from InterPro domain mapping is correct but very broad.
Reason: Immune response is a broad parent term. While it is less informative than the more specific inflammatory response or eosinophil chemotaxis terms, it is not incorrect for this chemokine.
|
|
GO:0008009
chemokine activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for chemokine activity, redundant with the IBA and IDA annotations for the same term. Correct.
Reason: Correct core molecular function. Redundant with higher-evidence annotations.
|
|
GO:0005515
protein binding
|
IPI
PMID:18275857 Stromal cell-derived factors 1alpha and 1beta, inflammatory ... |
MODIFY |
Summary: This IPI annotation is from a study on dipeptidyl peptidase 8 (DPP8) substrates. The paper tested 27 chemokines for cleavage by DPP8, and CCL11 was among those surveyed but was NOT identified as a novel substrate of DPP8 (the novel substrates were IP10/CXCL10, ITAC/CXCL11, and SDF-1/CXCL12). The WITH column shows UniProtKB:P27487 (DPP4). This likely reflects a physical interaction detected by IntAct, but the term "protein binding" is uninformative.
Reason: Protein binding is uninformative per curation guidelines. CCL11 can be processed by DPP4 (CD26) via N-terminal truncation, which is a well-known regulatory mechanism for chemokines. A more informative annotation would capture this as a substrate relationship. However, the interaction with DPP4 is real and documented.
Proposed replacements:
protein binding
Supporting Evidence:
PMID:18275857
N-terminal truncation of chemokines by proteases including dipeptidyl peptidase (DP) IV significantly alters their biological activity; generally ablating cognate G-protein coupled receptor engagement and often generating potent receptor antagonists.
|
|
GO:0005515
protein binding
|
IPI
PMID:21314817 Neuropeptide Y, B-type natriuretic peptide, substance P and ... |
MODIFY |
Summary: This IPI annotation from a study on fibroblast activation protein-alpha (FAP) substrates. The WITH column shows UniProtKB:P27487 (DPP4). The paper explicitly states that FAP showed negligible or no hydrolysis of chemokines that are readily hydrolysed by DPP4. This suggests the annotation reflects the CCL11-DPP4 interaction rather than CCL11-FAP interaction.
Reason: Protein binding is uninformative per curation guidelines. The interaction with DPP4 is the relevant binding interaction here.
Proposed replacements:
protein binding
Supporting Evidence:
PMID:21314817
FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4.
|
|
GO:0005515
protein binding
|
IPI
PMID:23597562 Inhibition of tumor angiogenesis and growth by a small-molec... |
MODIFY |
Summary: This IPI annotation is from a study on a small-molecule FGF receptor blocker. The WITH column shows UniProtKB:P51677 (CCR3). This reflects the CCL11-CCR3 physical interaction. While the paper itself is about FGF receptor inhibition, the IntAct interaction data likely captures the well-known CCL11-CCR3 binding.
Reason: Protein binding is uninformative. The actual interaction is CCL11 binding to CCR3, which is already captured by the more specific CCR3 chemokine receptor binding annotation (GO:0031728). This protein binding annotation should be replaced with the more specific term.
Proposed replacements:
CCR3 chemokine receptor binding
Supporting Evidence:
PMID:23597562
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
|
|
GO:0005515
protein binding
|
IPI
PMID:28381538 Chemokine interactome mapping enables tailored intervention ... |
MODIFY |
Summary: This IPI annotation is from the chemokine interactome mapping study by von Hundelshausen et al. (2017). The study systematically mapped chemokine-chemokine interactions using immunoligand blotting and surface plasmon resonance. CCL11 was found to interact with multiple chemokines including CCL5/RANTES, PF4/CXCL4, CXCL10, CXCL12, CCL27, and CCL28. These are functionally relevant heteromeric interactions that can modulate chemokine activity.
Reason: Protein binding is uninformative. The specific interactions documented in this study (chemokine-chemokine heterodimer formation) are biologically meaningful but "protein binding" does not capture this. A better term would reflect the chemokine-chemokine interaction specifically.
Proposed replacements:
CCR chemokine receptor binding
Supporting Evidence:
PMID:28381538
Heterophilic interactions between chemokines in a given microenvironment may amplify, inhibit, or modulate their activity; however, a systematic evaluation of the chemokine interactome has not been performed.
|
|
GO:0002544
chronic inflammatory response
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara ortholog transfer (rat Ccl11). CCL11 is involved in chronic inflammatory conditions such as asthma and atopic dermatitis. The annotation is plausible but represents a more specific inflammatory context.
Reason: CCL11 is involved in chronic inflammatory conditions (asthma, atopic dermatitis, RA), but this is a downstream consequence of its chemotactic function rather than a distinct core function. Keeping as non-core.
|
|
GO:0002551
mast cell chemotaxis
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (rat ortholog). While CCR3 is expressed on mast cells and CCL11 can theoretically attract mast cells via CCR3, the primary evidence for CCL11 chemotactic activity is for eosinophils. In the AMD study (PMID:19525930), despite eotaxin expression, mast cells were NOT recruited, suggesting this function may be context-dependent.
Reason: While theoretically possible given CCR3 expression on mast cells, the evidence for CCL11-mediated mast cell chemotaxis is limited. In the AMD context (PMID:19525930), mast cells were not recruited despite eotaxin abundance. Eosinophil chemotaxis is the primary chemotactic function.
Supporting Evidence:
PMID:19525930
despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV.
|
|
GO:0007015
actin filament organization
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 signaling through CCR3 induces cytoskeletal rearrangement including actin polymerization, as demonstrated in eosinophils (PMID:10072545) and endothelial cells (PMID:19525930). This is a downstream effect of chemokine signaling rather than a direct function of the ligand.
Reason: Actin filament organization occurs in responding cells as a consequence of CCR3 activation by CCL11, not as a direct biochemical function of the CCL11 protein itself. This is a downstream cellular response to the chemokine signal.
|
|
GO:0007611
learning or memory
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (mouse ortholog Ccl11, P48298). Recent reviews describe CCL11 as contributing to cognitive impairment by inhibiting neurogenesis, reducing synaptic density, and promoting neuronal cytotoxicity via CCR3 on microglia. However, this is a pleiotropic effect observed in aging contexts, not a core evolved function.
Reason: The link between CCL11 and learning/memory is based on aging studies in mice where elevated blood CCL11 impairs hippocampal neurogenesis and cognition. This is a pleiotropic pathological effect in aging rather than a core evolved function of the chemokine.
|
|
GO:0035962
response to interleukin-13
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by IL-13 (a type-2 cytokine) in various cell types. This annotation likely reflects that CCL11 gene expression responds to IL-13 signaling, which is well-established in the context of type-2 inflammation.
Reason: This describes the regulation of CCL11 expression rather than a function of the CCL11 protein. CCL11 production is induced by IL-13, but this is about gene regulation, not protein function. Keep as non-core contextual information.
|
|
GO:0045766
positive regulation of angiogenesis
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (mouse ortholog). CCL11 promotes angiogenesis through CCR3 on endothelial cells, as demonstrated in the AMD/choroidal neovascularization study (PMID:19525930). Eotaxins stimulated endothelial cell proliferation, actin polymerization, and migration. This is a well-supported non-core function.
Reason: While experimentally supported (PMID:19525930), positive regulation of angiogenesis is a secondary/pleiotropic function of CCL11 rather than its core evolved chemotactic function. It occurs in specific pathological contexts like AMD where CCR3 is expressed on neovascular endothelial cells.
Supporting Evidence:
PMID:19525930
each of the three eotaxins stimulated human CEC proliferation
|
|
GO:0048245
eosinophil chemotaxis
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA from Ensembl Compara (rat ortholog). Redundant with IBA and IDA annotations for the same term. Eosinophil chemotaxis is the core function of CCL11.
Reason: Correct core function. Redundant with higher-evidence annotations but independently derived from ortholog transfer.
|
|
GO:0050768
negative regulation of neurogenesis
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (mouse ortholog). CCL11 has been shown to inhibit neurogenesis in mouse aging studies. This is a pleiotropic effect linked to aging rather than a core function.
Reason: Negative regulation of neurogenesis is a secondary/aging-related effect of CCL11 observed in mouse studies, not a core evolved function of this chemokine.
|
|
GO:0070371
ERK1 and ERK2 cascade
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 activates ERK2 and p38 MAP kinases in eosinophils (PMID:10706854). This is a downstream signaling event triggered by CCR3 activation, not a direct function of CCL11 itself.
Reason: The ERK1/ERK2 cascade is activated downstream of CCR3 signaling upon CCL11 binding. While experimentally demonstrated, this describes a downstream signaling consequence in the responding cell, not a direct function of the secreted chemokine ligand. The annotation is on the gene product that triggers the cascade as a ligand, which is a somewhat indirect relationship.
Supporting Evidence:
PMID:10706854
Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38.
|
|
GO:0070670
response to interleukin-4
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by IL-4 signaling (via STAT6), which is well-established in the type-2 inflammation context. This annotation describes regulation of CCL11 gene expression rather than a function of the CCL11 protein.
Reason: This describes gene regulation (CCL11 expression is induced by IL-4) rather than a function of the CCL11 protein product. Keep as non-core contextual information.
|
|
GO:0060326
cell chemotaxis
|
IDA
PMID:33846499 Eotaxin-1/CCL11 is involved in cell migration in rheumatoid ... |
ACCEPT |
Summary: IDA annotation from PMID:33846499 (Wakabayashi et al., 2021). This study demonstrated that CCL11 induces migration of RA fibroblast-like synoviocytes (FLS) and THP-1 monocytes in transwell migration assays. CCL11-stimulated FLS migrated significantly more than unstimulated cells, and CCL11 siRNA knockdown reduced FLS migration.
Reason: Cell chemotaxis is a core function of CCL11 as a chemokine. This study provides direct experimental evidence that CCL11 induces directed cell migration in multiple cell types beyond eosinophils, including fibroblast-like synoviocytes and monocytes.
Supporting Evidence:
PMID:33846499
CCL11-stimulated cells migrated significantly more efficiently than unstimulated cells (mean ± SEM, number of cells per field; 35.8 ± 5.2 and 24.5 ± 4.6, respectively, p < 0.05, Fig. 5A)
|
|
GO:0070098
chemokine-mediated signaling pathway
|
IDA
PMID:19525930 CCR3 is a target for age-related macular degeneration diagno... |
ACCEPT |
Summary: IDA annotation from Takeda et al. (2009, Nature). The study demonstrated that CCL11 (eotaxin-1) activates CCR3-mediated signaling in choroidal endothelial cells, promoting proliferation, actin polymerization, Rac-1 activation, and migration. This is direct evidence of CCL11 initiating chemokine-mediated signaling.
Reason: Well-supported by experimental evidence in the Nature paper. CCL11 binding to CCR3 activates downstream signaling cascades in endothelial cells, constituting chemokine-mediated signaling.
Supporting Evidence:
PMID:19525930
Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules
|
|
GO:0050768
negative regulation of neurogenesis
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferred from mouse ortholog (P48298). CCL11 has been shown to inhibit hippocampal neurogenesis in aging mouse studies. This is a pleiotropic effect related to aging/neuroinflammation rather than a core function.
Reason: Based on sequence similarity to mouse Ccl11 which was experimentally shown to inhibit neurogenesis. This is a pleiotropic aging-related effect, not a core evolved function. Redundant with IEA annotation.
|
|
GO:0007611
learning or memory
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferred from mouse ortholog (P48298). CCL11 affects learning and memory in mouse aging studies. This is a pleiotropic neuroinflammatory effect. Redundant with IEA annotation.
Reason: Pleiotropic aging-related effect transferred from mouse ortholog studies. Not a core evolved function of this chemokine.
|
|
GO:0046983
protein dimerization activity
|
IDA
PMID:9712872 Solution structure of eotaxin, a chemokine that selectively ... |
ACCEPT |
Summary: IDA annotation from the NMR structural study by Crump et al. (1998). The study determined the solution structure of eotaxin and found it exists in equilibrium between monomer and dimer under a wide range of conditions. At pH <= 5 and low ionic strength, eotaxin was predominantly monomeric. This is a genuine biophysical property of the protein.
Reason: Protein dimerization is an experimentally demonstrated property of CCL11. Many CC chemokines form dimers, and this is likely biologically relevant for creating chemokine gradients and modulating activity.
Supporting Evidence:
PMID:9712872
The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions.
|
|
GO:0031728
CCR3 chemokine receptor binding
|
IDA
PMID:11425309 NMR solution structure and backbone dynamics of the CC chemo... |
ACCEPT |
Summary: IDA annotation from the eotaxin-3 structural study. Note that PMID:11425309 is actually about eotaxin-3 (CCL26), not eotaxin-1 (CCL11). However, CCL11 binding to CCR3 is very well established from multiple other studies (PMID:8631813, PMID:10072545). The reference may be incorrectly assigned but the annotation itself is correct.
Reason: CCR3 binding is the core molecular function of CCL11. While the specific reference (about eotaxin-3 structure) may not be the best citation for CCL11 specifically, the function is unambiguously correct and well-established from the original cloning papers (PMID:8631813).
Supporting Evidence:
PMID:9712872
The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy.
|
|
GO:0048018
receptor ligand activity
|
IDA
PMID:11425309 NMR solution structure and backbone dynamics of the CC chemo... |
ACCEPT |
Summary: IDA annotation. CCL11 is a receptor ligand (for CCR3). This is a fundamental molecular function description -- CCL11 acts as a ligand that activates a receptor (CCR3 GPCR). While the reference is about eotaxin-3, the function is correct for CCL11.
Reason: Receptor ligand activity is a core molecular function of CCL11. It acts as a signaling ligand for the CCR3 G-protein coupled receptor.
|
|
GO:0005576
extracellular region
|
IDA
PMID:20041150 Missense mutations in the MEFV gene are associated with fibr... |
ACCEPT |
Summary: IDA annotation with reference to PMID:20041150, a paper about MEFV gene mutations in fibromyalgia. This paper measured CCL11 levels in plasma, demonstrating it is present in the extracellular region (blood). The annotation is correct for CCL11 localization.
Reason: CCL11 is a secreted protein found in the extracellular region. The reference measured CCL11 in plasma, confirming its extracellular localization. While the paper is primarily about MEFV, the detection of CCL11 in plasma supports the annotation.
|
|
GO:0007010
cytoskeleton organization
|
IDA
PMID:10072545 Differential regulation of eosinophil chemokine signaling vi... |
KEEP AS NON CORE |
Summary: IDA annotation from Sabroe et al. (1999). The study showed that eotaxin induces leukocyte shape change mediated through rearrangements of the cellular cytoskeleton, essential for leukocyte migration. This is a downstream cellular response to CCL11/CCR3 signaling in responding cells.
Reason: Cytoskeleton organization in eosinophils is a downstream consequence of CCR3 activation by CCL11, not a direct function of the CCL11 protein. The ligand triggers cytoskeletal changes in the responding cell.
Supporting Evidence:
PMID:10072545
Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation.
|
|
GO:0008009
chemokine activity
|
IDA
PMID:10072545 Differential regulation of eosinophil chemokine signaling vi... |
ACCEPT |
Summary: IDA annotation from Sabroe et al. (1999). The study directly demonstrated that eotaxin acts as a chemokine by inducing rapid shape change and chemotactic responses in eosinophils via CCR3. This is direct experimental evidence for chemokine activity.
Reason: Core molecular function demonstrated by direct experimental evidence. Eotaxin was shown to be among the most potent CCR3-acting chemokines for eosinophil activation.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
|
|
GO:0008360
regulation of cell shape
|
IDA
PMID:10072545 Differential regulation of eosinophil chemokine signaling vi... |
KEEP AS NON CORE |
Summary: IDA annotation from Sabroe et al. (1999). CCL11 induces eosinophil shape change through cytoskeletal rearrangement. This is a downstream cellular response to CCR3 activation in responding cells.
Reason: Regulation of cell shape is a downstream consequence of CCR3 signaling in eosinophils. While experimentally demonstrated, it is not a core function of the CCL11 protein itself but rather a response in target cells.
Supporting Evidence:
PMID:10072545
Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell
|
|
GO:0048245
eosinophil chemotaxis
|
IDA
PMID:10072545 Differential regulation of eosinophil chemokine signaling vi... |
ACCEPT |
Summary: IDA annotation from Sabroe et al. (1999). Direct experimental demonstration that eotaxin induces eosinophil chemotaxis via CCR3. This is the core biological function of CCL11.
Reason: Core function of CCL11 directly demonstrated experimentally. Eotaxin is among the most potent eosinophil chemoattractants acting via CCR3.
Supporting Evidence:
PMID:10072545
Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent.
|
|
GO:0001938
positive regulation of endothelial cell proliferation
|
IDA
PMID:19525930 CCR3 is a target for age-related macular degeneration diagno... |
KEEP AS NON CORE |
Summary: IDA annotation from Takeda et al. (2009, Nature). The study showed that each of the three eotaxins (including CCL11) stimulated human choroidal endothelial cell (CEC) proliferation, and CCR3 neutralizing antibodies reduced CEC proliferation in vivo. This is a well-supported but non-core function in the context of choroidal neovascularization.
Reason: While experimentally well-supported in a high-impact publication, this function is specific to the pathological context of choroidal neovascularization in AMD, where CCR3 is aberrantly expressed on endothelial cells. It is not the core evolved function of CCL11.
Supporting Evidence:
PMID:19525930
each of the three eotaxins stimulated human CEC proliferation
|
|
GO:0030335
positive regulation of cell migration
|
IDA
PMID:19525930 CCR3 is a target for age-related macular degeneration diagno... |
ACCEPT |
Summary: IDA annotation from Takeda et al. (2009). CCL11 promoted human CEC migration in a dose-dependent fashion, and activated Rac-1, a GTPase critical for endothelial cell spreading and migration. This reinforces the IBA annotation.
Reason: Positive regulation of cell migration is a core function of CCL11 as a chemokine. This IDA provides additional experimental evidence in endothelial cells beyond the eosinophil context.
Supporting Evidence:
PMID:19525930
All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f).
|
|
GO:0030838
positive regulation of actin filament polymerization
|
IDA
PMID:19525930 CCR3 is a target for age-related macular degeneration diagno... |
KEEP AS NON CORE |
Summary: IDA annotation from Takeda et al. (2009). Stimulation of human CECs with eotaxins induced rapid polymerization of actin molecules. This is a downstream cellular response to CCR3 signaling in endothelial cells.
Reason: Actin polymerization is a downstream cellular response in target cells following CCR3 activation by CCL11. It is not a direct function of the CCL11 protein itself but rather a consequence of its signaling activity.
Supporting Evidence:
PMID:19525930
Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-443986 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "Receptor ACKR2 binds most inflammatory CC chemokines". CCL11 is a secreted protein that binds to ACKR2 (a decoy chemokine receptor) in the extracellular region. This is consistent with its localization as a secreted chemokine.
Reason: Correct localization for a secreted chemokine, supported by Reactome pathway curation.
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-6793978 |
ACCEPT |
Summary: TAS annotation from Reactome pathway "Expression of STAT6-upregulated extracellular proteins". CCL11 is a STAT6-induced secreted protein, consistent with its regulation by IL-4/IL-13 signaling and extracellular localization.
Reason: Correct localization. CCL11 is a STAT6-regulated secreted protein.
|
|
GO:0006468
protein phosphorylation
|
TAS
PMID:10706854 Eotaxin induces degranulation and chemotaxis of eosinophils ... |
MODIFY |
Summary: TAS annotation citing Kampen et al. (2000). The paper shows that eotaxin induces phosphorylation of ERK2 and p38 in eosinophils. However, CCL11 is NOT a kinase -- it is a secreted chemokine ligand. The phosphorylation events are downstream signaling consequences in responding cells following CCR3 activation. Annotating CCL11 with "protein phosphorylation" is misleading as it implies CCL11 catalyzes phosphorylation.
Reason: CCL11 is a secreted chemokine with no kinase activity. The paper demonstrates that eotaxin-induced CCR3 signaling triggers phosphorylation of ERK2 and p38 in eosinophils, but CCL11 does not directly catalyze phosphorylation. The annotation should be modified to reflect that CCL11 triggers signaling cascades in responding cells. A more appropriate annotation would capture the upstream signaling role.
Proposed replacements:
chemokine-mediated signaling pathway
Supporting Evidence:
PMID:10706854
Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38. Phosphorylation was detectable after 30 seconds, peaked at about 1 minute, and returned to baseline after 2 to 5 minutes.
|
|
GO:0006874
intracellular calcium ion homeostasis
|
TAS
PMID:10415069 Chemokine receptor expression and signaling in macaque and h... |
MARK AS OVER ANNOTATED |
Summary: TAS annotation from Klein et al. (1999). The study showed that CCR3 on neurons responds to its chemokine ligands (including eotaxin/CCL11) with increases in intracellular calcium. However, calcium mobilization is a downstream signaling event in CCR3-expressing cells, not a direct function of the CCL11 ligand itself. Additionally, the term "homeostasis" is misleading -- CCL11 triggers transient calcium flux rather than maintaining calcium homeostasis.
Reason: Intracellular calcium ion homeostasis is a downstream signaling event in CCR3-expressing cells after CCL11 binding. CCL11 triggers transient calcium mobilization but does not maintain calcium homeostasis. This represents an over-annotation where a downstream response in target cells is attributed to the signaling ligand.
Supporting Evidence:
PMID:10415069
Chemokine receptors were shown to respond to their appropriate chemokine ligands with increases in intracellular calcium that, in the case of neurons, required predepolarization with KCl.
|
|
GO:0006935
chemotaxis
|
TAS
PMID:10706854 Eotaxin induces degranulation and chemotaxis of eosinophils ... |
ACCEPT |
Summary: TAS annotation from Kampen et al. (2000). The study directly demonstrated eotaxin-induced eosinophil chemotaxis using Boyden microchambers and showed that MAP kinase inhibitors blocked this chemotaxis.
Reason: Chemotaxis is a core function of CCL11. This TAS annotation is well-supported by the referenced study and consistent with multiple other annotations.
Supporting Evidence:
PMID:10706854
We conclude that eotaxin induces a rapid concentration-dependent activation of ERK2 and p38 in eosinophils and that the activation of these MAP kinases is required for eotaxin-stimulated degranulation and directed locomotion.
|
|
GO:0006954
inflammatory response
|
TAS
PMID:10708591 Cell-type-dependent induction of eotaxin and CCR3 by ionizin... |
ACCEPT |
Summary: TAS annotation from Huber et al. (2000). The paper describes induction of eotaxin and CCR3 by ionizing radiation and discusses CCL11 in the context of eosinophilic inflammatory diseases.
Reason: Inflammatory response is a core process for CCL11. The paper directly discusses CCL11 in the context of eosinophilic inflammatory pathogenesis.
Supporting Evidence:
PMID:10708591
Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3.
|
|
GO:0007155
cell adhesion
|
TAS
PMID:10201960 Eotaxin activates T cells to chemotaxis and adhesion only if... |
KEEP AS NON CORE |
Summary: TAS annotation from Jinquan et al. (1999). The study showed that eotaxin, in combination with IL-2 and IL-4, enhances expression of adhesion molecules (ICAM-1, CD29, CD49a, CD49b) on T lymphocytes and promotes adhesion and aggregation. However, the adhesion effect required prior IL-2/IL-4 stimulation to induce CCR3 expression on T cells and is an indirect consequence of chemokine signaling.
Reason: Cell adhesion promotion by CCL11 is context-dependent (requires IL-2/IL-4 co-stimulation to induce CCR3 on T cells) and is a downstream consequence of CCR3 signaling rather than a direct adhesion function.
Supporting Evidence:
PMID:10201960
In combination with IL-2 and IL-4, eotaxin enhances the expression of adhesion molecules such as ICAM-1 and several integrins (CD29, CD49a, and CD49b) on T lymphocytes and thus promotes adhesion and aggregation of T lymphocytes.
|
|
GO:0007165
signal transduction
|
TAS
PMID:10706854 Eotaxin induces degranulation and chemotaxis of eosinophils ... |
ACCEPT |
Summary: TAS annotation from Kampen et al. (2000). The study demonstrated that eotaxin induces signal transduction through CCR3, activating ERK2 and p38 MAP kinases. Signal transduction is a very broad term; more specific terms are available.
Reason: While very broad, signal transduction is correct for CCL11 as a signaling ligand that activates receptor-mediated signaling cascades. More specific terms (chemokine-mediated signaling pathway) are also annotated.
|
|
GO:0009314
response to radiation
|
TAS
PMID:10708591 Cell-type-dependent induction of eotaxin and CCR3 by ionizin... |
MARK AS OVER ANNOTATED |
Summary: TAS annotation from Huber et al. (2000). The paper showed that CCL11 (eotaxin) expression is upregulated by ionizing radiation in human dermal fibroblasts. This describes the regulation of CCL11 gene expression in response to radiation, not a function of the CCL11 protein.
Reason: This annotation describes the induction of CCL11 gene expression by ionizing radiation, not a function of the CCL11 protein itself. The CCL11 protein does not sense or respond to radiation; rather, its expression is upregulated by radiation in certain cell types. This is an annotation about gene regulation inappropriately applied to the gene product.
Supporting Evidence:
PMID:10708591
the expression of eotaxin is upregulated upon treatment with ionizing radiation (IR) in human dermal fibroblasts
|
|
GO:0009615
response to virus
|
TAS
PMID:9558100 Dendritic cells express multiple chemokine receptors used as... |
MARK AS OVER ANNOTATED |
Summary: TAS annotation from Rubbert et al. (1998). The paper describes CCR3 as an HIV coreceptor on dendritic cells. CCR3 is identified as an eotaxin receptor on dendritic cells that may be used for HIV entry. However, this paper does not demonstrate a role for CCL11 in response to virus -- rather, it shows that the CCL11 receptor CCR3 can be exploited by HIV for cell entry. This is an over-annotation.
Reason: The cited paper describes CCR3 (the eotaxin receptor) as an HIV coreceptor on dendritic cells. This does not demonstrate that CCL11 protein itself participates in response to virus. The viral exploitation of CCR3 is a property of the receptor, not the chemokine ligand.
Supporting Evidence:
PMID:9558100
CCR3, the eotaxin receptor, initially identified on eosinophils, is expressed on DC and may be used as an entry coreceptor by certain dual-tropic strains.
|
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-03-06T03:10:19.457115'
end_time: '2026-03-06T03:20:07.995637'
duration_seconds: 588.54
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: CCL11
gene_symbol: CCL11
uniprot_accession: P51671
protein_description: 'RecName: Full=Eotaxin; AltName: Full=C-C motif chemokine 11;
AltName: Full=Eosinophil chemotactic protein; AltName: Full=Small-inducible cytokine
A11; Flags: Precursor;'
gene_info: Name=CCL11; Synonyms=SCYA11;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the intercrine beta (chemokine CC) family.
protein_domains: Chemokine_b/g/d. (IPR039809); Chemokine_CC_CS. (IPR000827); Chemokine_IL8-like_dom.
(IPR001811); Interleukin_8-like_sf. (IPR036048); IL8 (PF00048)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 29
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'CCL11' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene CCL11 (gene ID: CCL11, UniProt: P51671) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The UniProt accession P51671 corresponds to human CCL11, commonly called eotaxin‑1 and historically described as an eosinophil chemotactic protein; recent reviews continue to use these exact names and position it within the CC chemokine family (i.e., C‑C motif ligand 11). (wang2024spotlightonproinflammatory pages 6-7, wang2025emergingrolesof pages 4-5)
Functionally, the dominant, high‑affinity receptor is CCR3, which is repeatedly described as the principal receptor mediating canonical eotaxin‑1 biology (eosinophil recruitment/activation) and is consistent with CCL11 being a secreted chemokine ligand rather than an enzyme or transporter. (wang2025emergingrolesof pages 4-5, xie2024immunologicaspectsof pages 9-10)
CCL11 is a chemokine ligand that forms gradients in tissues and is best known for selective recruitment of eosinophils in type‑2/allergic inflammation. (wang2025emergingrolesof pages 4-5, wang2025emergingrolesof pages 2-4)
CCR3 is described as the main/high‑affinity receptor for CCL11 and as a G‑protein‑coupled receptor whose signaling is associated with intracellular calcium mobilization, supporting chemotaxis and activation in CCR3+ immune cells. (wang2025emergingrolesof pages 4-5)
In asthma-focused synthesis, CCR3 is selectively activated by eotaxin‑1 (CCL11) (as well as eotaxin‑2/CCL24 and eotaxin‑3/CCL26), and CCR3 activation—together with endothelial adhesion molecules—facilitates eosinophil recruitment from blood into lung tissues. (xie2024immunologicaspectsof pages 9-10)
A recent focused review summarizes additional functional interactions: CCL11 can act as a CCR5 agonist (and can induce CCR5 internalization in monocytes/macrophages) and has complex/controversial CCR2 activity (reported as partial agonist in some settings or as a natural antagonist in others). (wang2025emergingrolesof pages 4-5)
Across recent reviews, CCL11 production is attributed to many cell types, including eosinophils, T and B cells, fibroblasts, epithelial cells, endothelial cells, macrophages, and in CNS discussions also microglia. (wang2024spotlightonproinflammatory pages 6-7, wang2025emergingrolesof pages 2-4)
Type‑2 cytokines are repeatedly cited as upstream inducers; for example, Th2 cytokines IL‑4, IL‑10, and IL‑13 induce CCL11 production in a 2024 review of chemokines in cognitive impairment. (wang2024spotlightonproinflammatory pages 6-7)
CCL11 is not an enzyme; its primary biochemical role is chemokine signaling as a soluble ligand that binds chemokine receptors and orchestrates directed cell migration and related activation programs.
CCL11 is treated in recent literature as an extracellular, secreted mediator that can function in blood and tissues and—importantly for CNS indications—can be transported from blood to brain via the blood–brain barrier (BBB). (wang2024spotlightonproinflammatory pages 6-7)
A 2024 asthma immunology review describes a mechanistic module in which eotaxin‑1 (CCL11) selectively activates CCR3 and, together with endothelial adhesion molecule expression—especially VCAM‑1 and ICAM‑1—supports recruitment/extravasation of eosinophils from blood into lung mucosa and interstitium. (xie2024immunologicaspectsof pages 9-10)
A more mechanistic, multi-context synthesis highlights airway‑relevant producers and inductive pathways: bronchial epithelial cells can be induced via IL‑4/STAT6, and airway smooth muscle cells via IL‑17A‑driven MAPK pathways (p38/JNK/ERK); eosinophils themselves can be major sources, supporting an autocrine chemotactic loop. (wang2025emergingrolesof pages 2-4)
A 2024 Frontiers in Immunology review frames CCL11 as an aging/accelerated aging immune marker and summarizes mechanistic links to cognition: CCL11 can contribute to cognitive impairment by inhibiting neurogenesis, reducing synaptic density, and promoting neuronal cytotoxicity. (wang2024spotlightonproinflammatory pages 6-7, wang2024spotlightonproinflammatory pages 7-8)
Mechanistically, the same review proposes a microglial pathway in which CCL11 binding to CCR3 on microglia upregulates NOX‑1, increases microglial ROS, and drives inflammation-associated neuronal injury/death. (wang2024spotlightonproinflammatory pages 6-7)
A recent mechanistic synthesis describes evidence that CCL11 can act on CCR3+ endothelial cells to promote angiogenic responses and can signal through pathways including PI3K/Akt and ERK/p38, and can upregulate matrix remodeling enzymes (e.g., MMP-2/3) in a CCR3-dependent fashion. (wang2025emergingrolesof pages 7-9)
Lavandoski et al. (Frontiers in Immunology; published Oct 2023; https://doi.org/10.3389/fimmu.2023.1243537) tested recombinant human CCL11 (rhCCL11) in MRC‑5 human lung fibroblasts.
Key findings include:
- High‑dose rhCCL11 (500 ng/10^5 cells/mL) induced ROS overproduction within 60 minutes and persisting up to 4 hours (p<0.05). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
- rhCCL11 increased DNA damage response markers at 2 hours, with increased γH2AX (% positive p<0.0001; MFI p=0.005) and phospho‑TP53 (% positive p<0.0001; MFI p=0.0352), resolving by 24 hours. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
- A 24‑hour rhCCL11 exposure increased SA‑β‑gal senescence readout (percentage p=0.0481; MFI p=0.0229) and reduced proliferation marker Ki‑67 (p=0.0192). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
- rhCCL11 also promoted a pro-inflammatory senescence-associated secretory phenotype (SASP), increasing CCL11 secretion (p<0.0001) and increasing IL‑6 (p=0.0005) and IL‑8 (p=0.0008). (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
These data extend CCL11 functional annotation beyond chemotaxis by supporting direct, receptor-mediated (or receptor-associated) cellular stress programs in structural lung cells relevant to chronic airway disease biology. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7)
Visual evidence from the primary paper: cropped panels for ROS kinetics and DNA-damage marker flow cytometry are available. (lavandoski2023eotaxin1ccl11promotescellular media 88940820, lavandoski2023eotaxin1ccl11promotescellular media ba4c996b)
Wang et al. (Frontiers in Immunology; published Jul 2024; https://doi.org/10.3389/fimmu.2024.1421076) provides a 2024 review synthesis emphasizing that CCL11 can cross the BBB and engage CCR3 on CNS cells, and highlights microglial oxidative mechanisms (NOX‑1 → ROS) as a plausible route to neurotoxicity. (wang2024spotlightonproinflammatory pages 6-7)
Xie et al. (Frontiers in Immunology; published Oct 2024; https://doi.org/10.3389/fimmu.2024.1478624) integrates CCL11 into the type‑2 asthma effector framework in which CCR3 activation by eotaxins enables eosinophil recruitment, coordinated with IL‑4/IL‑13-driven endothelial adhesion molecule priming (VCAM‑1/ICAM‑1). (xie2024immunologicaspectsof pages 9-10)
Negrin et al. (Journal of Clinical Medicine; published Jul 2024; https://doi.org/10.3390/jcm13144218) evaluated serum eotaxin (CCL11) in a matched polytrauma cohort.
Reported performance characteristics include:
- ROC AUC = 0.718 for admission eotaxin level identifying TBI (limited clinical utility). (negrin2024differencesineotaxin pages 1-2, negrin2024differencesineotaxin pages 9-10)
- A cutoff of 154 pg/mL yielded sensitivity 0.707 and specificity 0.683. (negrin2024differencesineotaxin pages 1-2)
- Odds of prevalent TBI increased 10.5% per 20 pg/mL increase in admission eotaxin. (negrin2024differencesineotaxin pages 1-2)
This is a concrete example of CCL11 deployment as an acute-care biomarker candidate, with quantified performance. (negrin2024differencesineotaxin pages 1-2)
ClinicalTrials.gov includes observational implementations where eotaxin/CCL11 is an analyte:
NCT06211244 (Sponsor: Tungs’ Taichung Metroharbour Hospital) “Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients” (Status: Completed; Start 2024-05-02, Completion 2024-12-31; Enrollment 291). Primary outcome: serum eotaxin biomarker analysis by ELISA; includes secondary inflammatory/oxidative injury markers (IL‑6, MCP‑1, 8‑isoprostane) and cardiac injury marker hs‑troponin I. (NCT06211244 chunk 1)
NCT03521882 (Royal Devon and Exeter NHS Foundation Trust) “Timed Interval Measurement of Eotaxin in Stroke Study” (Status: Completed; Start 2017-05-22; Completion 2019-05-30). Primary outcome: plasma eotaxin concentration tracked across 0–7 days after stroke-like presentations to define kinetics/feasibility for larger studies. (NCT03521882 chunk 1)
These registry entries reflect real-world implementation of CCL11 measurement as a clinical research biomarker rather than a therapeutic product. (NCT06211244 chunk 1, NCT03521882 chunk 1)
Across recent reviews, there is strong consensus that:
1) CCL11–CCR3 is the core axis for eosinophil recruitment/activation in type‑2 inflammation, with CCL11 being one of the eotaxins that selectively activate CCR3. (xie2024immunologicaspectsof pages 9-10, wang2025emergingrolesof pages 4-5)
2) CCL11 has pleiotropic context-dependent biology beyond eosinophil chemotaxis (e.g., tissue remodeling/angiogenesis, CNS effects), and may act via CCR3 on non-hematopoietic cells and through additional chemokine receptors in certain contexts (CCR5; CCR2 disputed). (wang2025emergingrolesof pages 7-9, wang2025emergingrolesof pages 4-5)
3) In CNS contexts, CCL11 is increasingly discussed as part of inflammatory aging frameworks and neuroinflammation, including oxidative stress mechanisms in microglia. (wang2024spotlightonproinflammatory pages 6-7)
CCL11 (eotaxin‑1) is a secreted CC chemokine ligand whose canonical function is CCR3‑dependent chemotaxis and activation of eosinophils (and other CCR3+ type‑2 immune cells), central to type‑2/allergic inflammation including asthma, where eosinophil extravasation is coordinated with endothelial adhesion pathways. (xie2024immunologicaspectsof pages 9-10, wang2025emergingrolesof pages 4-5)
Beyond leukocyte trafficking, recent primary and review evidence supports roles in (i) neuroinflammation and cognitive impairment via BBB trafficking and microglial CCR3–NOX‑1–ROS signaling, and (ii) tissue remodeling/angiogenesis via CCR3+ endothelial signaling (e.g., PI3K/Akt, ERK/p38) and matrix remodeling programs. (wang2024spotlightonproinflammatory pages 6-7, wang2025emergingrolesof pages 7-9)
Finally, recombinant CCL11 can directly induce pro-oxidant DNA damage signaling and senescence-associated phenotypes in human lung fibroblasts, suggesting a mechanistic link between chronic inflammatory chemokines and structural-cell aging programs relevant to airway disease. (lavandoski2023eotaxin1ccl11promotescellular pages 5-7, lavandoski2023eotaxin1ccl11promotescellular media 88940820)
| Functional Context | Key Receptor & Signaling | Producing Cells / Inducers | Target Cells & Outcomes | Key Evidence / Statistics | Recent Source |
|---|---|---|---|---|---|
| Allergic Airway Disease | CCR3 (High affinity, primary); CCR5 (agonist); CCR2 (antagonist/partial). Signals via $Ca^{2+}$ mobilization (wang2025emergingrolesof pages 4-5). | Eosinophils (autocrine), Epithelium (IL-4/STAT6), Smooth Muscle (IL-17A/MAPK) (wang2025emergingrolesof pages 2-4). | Eosinophils, Basophils, Th2 cells. Drives chemotaxis, activation, and Th2 polarization (wang2025emergingrolesof pages 5-7). | Elevated CCR3/CCL11 correlates with asthma severity. CCR3 mediates extravasation via VCAM-1 interaction (xie2024immunologicaspectsof pages 9-10). | Wang et al. 2025 (wang2025emergingrolesof pages 1-2) Xie et al. 2024 (xie2024immunologicaspectsof pages 9-10) |
| Neuroinflammation & Cognitive Decline | CCR3 (Microglia). Upregulates NOX-1, increasing ROS production (wang2024spotlightonproinflammatory pages 6-7). | Neurons, Astrocytes, Microglia. Induced by IL-4, IL-13, aging factors (wang2024spotlightonproinflammatory pages 6-7). | Microglia, Neurons. Inhibits neurogenesis, reduces synaptic density, promotes cytotoxicity (wang2024spotlightonproinflammatory pages 6-7). | Anti-CCL11 Ab improved motor outcomes in PD mice (wang2024spotlightonproinflammatory pages 6-7). Plasma from aged mice impairs memory in young mice (wang2024spotlightonproinflammatory pages 7-8). | Wang et al. 2024 (wang2024spotlightonproinflammatory pages 6-7) |
| Angiogenesis & Tissue Remodeling | CCR3 (Endothelial). Signals via PI3K/Akt, ERK/p38 MAPK (wang2025emergingrolesof pages 7-9). | Endothelial cells, Fibroblasts (wang2025emergingrolesof pages 2-4). | Endothelial cells. Promotes chemotaxis, vascularization, and ECM remodeling (MMP-2/3) (wang2025emergingrolesof pages 7-9). | Recombinant CCL11 directly induces angiogenic responses in vivo and promotes HUVEC vascularization (wang2025emergingrolesof pages 7-9). | Wang et al. 2025 (wang2025emergingrolesof pages 7-9) |
| Cellular Senescence | CCR3. Activates DNA Damage Response (p-p53, $\gamma$H2AX) via ROS (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). | Lung Fibroblasts (Autocrine loop) (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). | Fibroblasts. Induces senescence (SA-$\beta$-gal), reduces proliferation (Ki-67), SASP secretion (IL-6/8) (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). | rhCCL11 (500 ng/mL) increased ROS (<60 min) and $\gamma$H2AX ($p<0.0001$, 2h); increased SA-$\beta$-gal at 24h ($p=0.048$) (lavandoski2023eotaxin1ccl11promotescellular pages 5-7). | Lavandoski et al. 2023 (lavandoski2023eotaxin1ccl11promotescellular pages 5-7) |
| TBI Biomarker | N/A (Systemic detection). | Brain tissue (sole source after TBI) (negrin2024differencesineotaxin pages 1-2). | Systemic circulation (Diagnostic marker). | Cutoff 154 pg/mL for TBI diagnosis: Sens 0.707, Spec 0.683, AUC 0.718. Odds +10.5% per 20 pg/mL increase (negrin2024differencesineotaxin pages 9-10). | Negrin et al. 2024 (negrin2024differencesineotaxin pages 1-2, negrin2024differencesineotaxin pages 9-10) |
| Clinical Trials | N/A | Patient Serum/Plasma levels. | Hemodialysis; Stroke patients. | NCT06211244 (2024): Serum Eotaxin/Myocardiac injury. NCT03521882: Plasma Eotaxin kinetics in stroke (NCT06211244 chunk 1, NCT03521882 chunk 1). | ClinicalTrials.gov (NCT06211244 chunk 1, NCT03521882 chunk 1) |
Table: A summary of human CCL11 functions, mechanisms, and clinical relevance based on recent literature, highlighting its dual roles in allergic inflammation and aging-associated pathologies.
References
(wang2024spotlightonproinflammatory pages 6-7): Chenxu Wang, Jiayi Wang, Zhichao Zhu, Jialing Hu, and Yong Lin. Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment. Frontiers in Immunology, Jul 2024. URL: https://doi.org/10.3389/fimmu.2024.1421076, doi:10.3389/fimmu.2024.1421076. This article has 26 citations and is from a peer-reviewed journal.
(wang2025emergingrolesof pages 4-5): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.
(xie2024immunologicaspectsof pages 9-10): Cong Xie, Jingyan Yang, Aman Gul, Yifan Li, Rui Zhang, Maimaititusun Yalikun, Xiaotong Lv, Yuhan Lin, Qingli Luo, and Huijuan Gao. Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation. Frontiers in Immunology, Oct 2024. URL: https://doi.org/10.3389/fimmu.2024.1478624, doi:10.3389/fimmu.2024.1478624. This article has 42 citations and is from a peer-reviewed journal.
(wang2025emergingrolesof pages 2-4): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.
(wang2024spotlightonproinflammatory pages 7-8): Chenxu Wang, Jiayi Wang, Zhichao Zhu, Jialing Hu, and Yong Lin. Spotlight on pro-inflammatory chemokines: regulators of cellular communication in cognitive impairment. Frontiers in Immunology, Jul 2024. URL: https://doi.org/10.3389/fimmu.2024.1421076, doi:10.3389/fimmu.2024.1421076. This article has 26 citations and is from a peer-reviewed journal.
(wang2025emergingrolesof pages 7-9): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.
(lavandoski2023eotaxin1ccl11promotescellular pages 5-7): Patrícia Lavandoski, Vinícius Pierdoná, Rafael Moura Maurmann, Lucas Kich Grun, Fatima T. C. R. Guma, and Florencia María Barbé-Tuana. Eotaxin-1/ccl11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1243537, doi:10.3389/fimmu.2023.1243537. This article has 29 citations and is from a peer-reviewed journal.
(lavandoski2023eotaxin1ccl11promotescellular media 88940820): Patrícia Lavandoski, Vinícius Pierdoná, Rafael Moura Maurmann, Lucas Kich Grun, Fatima T. C. R. Guma, and Florencia María Barbé-Tuana. Eotaxin-1/ccl11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1243537, doi:10.3389/fimmu.2023.1243537. This article has 29 citations and is from a peer-reviewed journal.
(lavandoski2023eotaxin1ccl11promotescellular media ba4c996b): Patrícia Lavandoski, Vinícius Pierdoná, Rafael Moura Maurmann, Lucas Kich Grun, Fatima T. C. R. Guma, and Florencia María Barbé-Tuana. Eotaxin-1/ccl11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1243537, doi:10.3389/fimmu.2023.1243537. This article has 29 citations and is from a peer-reviewed journal.
(negrin2024differencesineotaxin pages 1-2): Lukas L. Negrin, Robin Ristl, Gregor Wollner, and Stefan Hajdu. Differences in eotaxin serum levels between polytraumatized patients with and without concomitant traumatic brain injury—a matched pair analysis. Journal of Clinical Medicine, 13:4218, Jul 2024. URL: https://doi.org/10.3390/jcm13144218, doi:10.3390/jcm13144218. This article has 2 citations.
(negrin2024differencesineotaxin pages 9-10): Lukas L. Negrin, Robin Ristl, Gregor Wollner, and Stefan Hajdu. Differences in eotaxin serum levels between polytraumatized patients with and without concomitant traumatic brain injury—a matched pair analysis. Journal of Clinical Medicine, 13:4218, Jul 2024. URL: https://doi.org/10.3390/jcm13144218, doi:10.3390/jcm13144218. This article has 2 citations.
(NCT06211244 chunk 1): Association of Serum Eotaxin Levels and Markers of Myocardiac Injury in Hemodialysis Patients. Tungs' Taichung Metroharbour Hospital. 2024. ClinicalTrials.gov Identifier: NCT06211244
(NCT03521882 chunk 1): Timed Interval Measurement of Eotaxin in Stroke Study. Royal Devon and Exeter NHS Foundation Trust. 2017. ClinicalTrials.gov Identifier: NCT03521882
(wang2025emergingrolesof pages 5-7): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.
(wang2025emergingrolesof pages 1-2): Jiaqi Wang, Kwan Man, and Kevin Tak-Pan Ng. Emerging roles of c-c motif ligand 11 (ccl11) in cancers and liver diseases: mechanisms and therapeutic implications. International Journal of Molecular Sciences, 26:4662, May 2025. URL: https://doi.org/10.3390/ijms26104662, doi:10.3390/ijms26104662. This article has 7 citations.
id: P51671
gene_symbol: CCL11
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
CCL11 (also known as Eotaxin-1) is a secreted CC chemokine that functions as a potent
and selective chemoattractant for eosinophils. It signals primarily through the
G-protein-coupled receptor CCR3, inducing directed cell migration (chemotaxis),
cytoskeletal rearrangement, calcium mobilization, and activation of downstream
MAP kinase cascades (ERK2, p38). CCL11 is produced by fibroblasts, epithelial cells,
endothelial cells, macrophages, and eosinophils themselves, and is induced by
pro-inflammatory cytokines (TNF-alpha, IL-1alpha, IFN-gamma) and type-2 cytokines
(IL-4, IL-13). Beyond eosinophil recruitment in allergic inflammation (asthma, atopic
dermatitis), CCL11 also promotes endothelial cell proliferation and migration via
CCR3 in the context of choroidal neovascularization, and has been implicated in
neuroinflammation and cognitive decline via CCR3 signaling on microglia. The mature
protein is 74 amino acids (after signal peptide cleavage), adopts a typical chemokine
fold with a 3-stranded beta-sheet and overlying alpha-helix, and can exist in
monomer-dimer equilibrium. It is O-glycosylated at Thr-94.
existing_annotations:
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
CCL11/Eotaxin is a secreted chemokine that functions in the extracellular
space. UniProt annotates it as "Secreted" (PubMed:8597956). The IBA annotation
is consistent with phylogenetic inference across the CC chemokine family.
action: ACCEPT
reason: >-
CCL11 is a secreted protein that acts extracellularly to create chemotactic
gradients. This is well-established and consistent with the signal peptide
(residues 1-23) and its function as a soluble ligand for CCR3.
supported_by:
- reference_id: PMID:8597956
supporting_text: "Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia."
- term:
id: GO:0008009
label: chemokine activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
Chemokine activity is the core molecular function of CCL11. It acts as a
chemoattractant primarily for eosinophils via CCR3 (PMID:8631813, PMID:10072545).
The IBA annotation is phylogenetically sound across CC chemokines.
action: ACCEPT
reason: >-
CCL11 is definitively a chemokine. Its primary molecular function is to act
as a chemoattractant ligand, signaling through CCR3 to induce directed cell
migration. This is its canonical and core function.
supported_by:
- reference_id: PMID:10072545
supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."
- term:
id: GO:0070098
label: chemokine-mediated signaling pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
CCL11 is a chemokine ligand that initiates chemokine-mediated signaling through
CCR3. This is directly supported by multiple studies showing CCL11 binding to
CCR3 triggers downstream signaling cascades including MAP kinase activation
(PMID:10706854) and calcium mobilization (PMID:10415069).
action: ACCEPT
reason: >-
As a chemokine, CCL11 inherently participates in chemokine-mediated signaling
pathways by binding and activating its receptor CCR3. This is a core function.
supported_by:
- reference_id: PMID:10706854
supporting_text: "Eotaxin and other CC chemokines acting via CC chemokine receptor-3 (CCR3) are believed to play an integral role in the development of eosinophilic inflammation in asthma and allergic inflammatory diseases."
- term:
id: GO:0061844
label: antimicrobial humoral immune response mediated by antimicrobial peptide
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
This IBA annotation is propagated from the broader CC chemokine family. While
some chemokines have direct antimicrobial peptide activity, CCL11/Eotaxin is
primarily characterized as an eosinophil chemoattractant rather than a direct
antimicrobial peptide. The evidence for direct antimicrobial activity of CCL11
specifically is limited.
action: KEEP_AS_NON_CORE
reason: >-
While the IBA annotation reflects a phylogenetically-inferred function shared
across CC chemokines, CCL11 is not primarily known for direct antimicrobial
peptide activity. Its core function is eosinophil chemotaxis. Some CC chemokines
do have antimicrobial properties, and this may apply to CCL11 as well, but it
is not a core function.
- term:
id: GO:0048245
label: eosinophil chemotaxis
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
Eosinophil chemotaxis is the canonical and best-characterized biological
process of CCL11/Eotaxin. It was originally cloned as a specific eosinophil
chemoattractant (PMID:8597956, PMID:8631813). The IBA annotation reinforces
this across species.
action: ACCEPT
reason: >-
This is arguably the single most defining function of CCL11. It was named
"eotaxin" specifically for its eosinophil-selective chemotactic activity.
supported_by:
- reference_id: PMID:10072545
supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."
- term:
id: GO:0030335
label: positive regulation of cell migration
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
CCL11 promotes cell migration in multiple cell types. It induces eosinophil
chemotaxis (PMID:10072545), endothelial cell migration (PMID:19525930), and
FLS/monocyte migration (PMID:33846499). The IBA annotation is well-supported.
action: ACCEPT
reason: >-
As a chemokine, positive regulation of cell migration is a core function of
CCL11. This is supported by extensive experimental evidence across multiple
cell types and contexts.
supported_by:
- reference_id: PMID:19525930
supporting_text: "All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f)."
- term:
id: GO:0006954
label: inflammatory response
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
CCL11 is a pro-inflammatory chemokine that plays a central role in allergic
inflammatory responses by recruiting eosinophils to sites of inflammation.
This is well-established across multiple disease contexts including asthma
and atopic dermatitis.
action: ACCEPT
reason: >-
Involvement in inflammatory response is a core function of CCL11. It mediates
eosinophil recruitment in type-2/allergic inflammation, which is its primary
physiological role.
supported_by:
- reference_id: PMID:10708591
supporting_text: "Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3."
- term:
id: GO:0048020
label: CCR chemokine receptor binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
CCL11 binds CCR3 as its primary receptor (PMID:8631813). It can also interact
with CCR5 and has controversial/partial activity at CCR2. The IBA annotation
for CCR chemokine receptor binding is well-supported.
action: ACCEPT
reason: >-
CCR chemokine receptor binding is a core molecular function of CCL11. It binds
CCR3 with high affinity as its principal receptor. This is the parent term that
encompasses the more specific CCR3 binding, which is also annotated.
supported_by:
- reference_id: PMID:9712872
supporting_text: "The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy."
- term:
id: GO:0005125
label: cytokine activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
CCL11 is classified as a cytokine (specifically a chemokine, which is a
subclass of cytokines). The IEA annotation from UniProt keyword mapping is
correct but less specific than the chemokine activity annotation.
action: ACCEPT
reason: >-
Cytokine activity is a parent term of chemokine activity. While less specific,
it is not incorrect. The more specific chemokine activity term is also present.
Acceptable as a broader IEA annotation.
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
CCL11 is a secreted protein that localizes to the extracellular region.
This IEA annotation is consistent with domain-based predictions and the
established biology of chemokines.
action: ACCEPT
reason: >-
Extracellular region is a broader parent of extracellular space. Both are
correct for this secreted chemokine. The IEA annotation is consistent with
multiple higher-evidence annotations.
- term:
id: GO:0005615
label: extracellular space
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
Duplicate of the IBA annotation for the same term. CCL11 is secreted and
acts in the extracellular space. This IEA annotation is redundant with
the IBA annotation but not incorrect.
action: ACCEPT
reason: >-
Correct localization for a secreted chemokine. Redundant with IBA but
acceptable as independent evidence.
- term:
id: GO:0006935
label: chemotaxis
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
CCL11 is a chemotactic factor. The IEA annotation from UniProt keyword
mapping to chemotaxis is correct. More specific terms (eosinophil chemotaxis)
are also annotated.
action: ACCEPT
reason: >-
Chemotaxis is a core biological process for CCL11. This broader term is
acceptable alongside the more specific eosinophil chemotaxis annotation.
- term:
id: GO:0006954
label: inflammatory response
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
Duplicate of the IBA annotation for inflammatory response. CCL11 is clearly
involved in inflammatory responses. The IEA from keyword mapping is redundant
but correct.
action: ACCEPT
reason: >-
Correct annotation, redundant with IBA annotation for the same term.
- term:
id: GO:0006955
label: immune response
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
CCL11 participates in immune responses by recruiting eosinophils and other
immune cells. The IEA annotation from InterPro domain mapping is correct
but very broad.
action: ACCEPT
reason: >-
Immune response is a broad parent term. While it is less informative than
the more specific inflammatory response or eosinophil chemotaxis terms,
it is not incorrect for this chemokine.
- term:
id: GO:0008009
label: chemokine activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for chemokine activity, redundant with the IBA and IDA
annotations for the same term. Correct.
action: ACCEPT
reason: >-
Correct core molecular function. Redundant with higher-evidence annotations.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:18275857
review:
summary: >-
This IPI annotation is from a study on dipeptidyl peptidase 8 (DPP8) substrates.
The paper tested 27 chemokines for cleavage by DPP8, and CCL11 was among those
surveyed but was NOT identified as a novel substrate of DPP8 (the novel substrates
were IP10/CXCL10, ITAC/CXCL11, and SDF-1/CXCL12). The WITH column shows
UniProtKB:P27487 (DPP4). This likely reflects a physical interaction detected
by IntAct, but the term "protein binding" is uninformative.
action: MODIFY
reason: >-
Protein binding is uninformative per curation guidelines. CCL11 can be
processed by DPP4 (CD26) via N-terminal truncation, which is a well-known
regulatory mechanism for chemokines. A more informative annotation would
capture this as a substrate relationship. However, the interaction with DPP4
is real and documented.
proposed_replacement_terms:
- id: GO:0005515
label: protein binding
additional_reference_ids:
- PMID:18275857
supported_by:
- reference_id: PMID:18275857
supporting_text: "N-terminal truncation of chemokines by proteases including dipeptidyl peptidase (DP) IV significantly alters their biological activity; generally ablating cognate G-protein coupled receptor engagement and often generating potent receptor antagonists."
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21314817
review:
summary: >-
This IPI annotation from a study on fibroblast activation protein-alpha (FAP)
substrates. The WITH column shows UniProtKB:P27487 (DPP4). The paper explicitly
states that FAP showed negligible or no hydrolysis of chemokines that are
readily hydrolysed by DPP4. This suggests the annotation reflects the
CCL11-DPP4 interaction rather than CCL11-FAP interaction.
action: MODIFY
reason: >-
Protein binding is uninformative per curation guidelines. The interaction
with DPP4 is the relevant binding interaction here.
proposed_replacement_terms:
- id: GO:0005515
label: protein binding
supported_by:
- reference_id: PMID:21314817
supporting_text: "FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4."
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23597562
review:
summary: >-
This IPI annotation is from a study on a small-molecule FGF receptor blocker.
The WITH column shows UniProtKB:P51677 (CCR3). This reflects the CCL11-CCR3
physical interaction. While the paper itself is about FGF receptor inhibition,
the IntAct interaction data likely captures the well-known CCL11-CCR3 binding.
action: MODIFY
reason: >-
Protein binding is uninformative. The actual interaction is CCL11 binding to
CCR3, which is already captured by the more specific CCR3 chemokine receptor
binding annotation (GO:0031728). This protein binding annotation should be
replaced with the more specific term.
proposed_replacement_terms:
- id: GO:0031728
label: CCR3 chemokine receptor binding
supported_by:
- reference_id: PMID:23597562
supporting_text: "Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties."
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28381538
review:
summary: >-
This IPI annotation is from the chemokine interactome mapping study by von
Hundelshausen et al. (2017). The study systematically mapped chemokine-chemokine
interactions using immunoligand blotting and surface plasmon resonance. CCL11
was found to interact with multiple chemokines including CCL5/RANTES, PF4/CXCL4,
CXCL10, CXCL12, CCL27, and CCL28. These are functionally relevant
heteromeric interactions that can modulate chemokine activity.
action: MODIFY
reason: >-
Protein binding is uninformative. The specific interactions documented in this
study (chemokine-chemokine heterodimer formation) are biologically meaningful
but "protein binding" does not capture this. A better term would reflect
the chemokine-chemokine interaction specifically.
proposed_replacement_terms:
- id: GO:0048020
label: CCR chemokine receptor binding
supported_by:
- reference_id: PMID:28381538
supporting_text: "Heterophilic interactions between chemokines in a given microenvironment may amplify, inhibit, or modulate their activity; however, a systematic evaluation of the chemokine interactome has not been performed."
- term:
id: GO:0002544
label: chronic inflammatory response
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara ortholog transfer (rat Ccl11). CCL11 is involved
in chronic inflammatory conditions such as asthma and atopic dermatitis.
The annotation is plausible but represents a more specific inflammatory
context.
action: KEEP_AS_NON_CORE
reason: >-
CCL11 is involved in chronic inflammatory conditions (asthma, atopic dermatitis,
RA), but this is a downstream consequence of its chemotactic function rather
than a distinct core function. Keeping as non-core.
- term:
id: GO:0002551
label: mast cell chemotaxis
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (rat ortholog). While CCR3 is expressed on mast
cells and CCL11 can theoretically attract mast cells via CCR3, the primary
evidence for CCL11 chemotactic activity is for eosinophils. In the AMD study
(PMID:19525930), despite eotaxin expression, mast cells were NOT recruited,
suggesting this function may be context-dependent.
action: KEEP_AS_NON_CORE
reason: >-
While theoretically possible given CCR3 expression on mast cells, the evidence
for CCL11-mediated mast cell chemotaxis is limited. In the AMD context
(PMID:19525930), mast cells were not recruited despite eotaxin abundance.
Eosinophil chemotaxis is the primary chemotactic function.
supported_by:
- reference_id: PMID:19525930
supporting_text: "despite the expression of its ligands eotaxin-1, -2 and -3, neither eosinophils nor mast cells are present in human CNV."
- term:
id: GO:0007015
label: actin filament organization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (rat ortholog). CCL11 signaling through CCR3 induces
cytoskeletal rearrangement including actin polymerization, as demonstrated
in eosinophils (PMID:10072545) and endothelial cells (PMID:19525930). This is
a downstream effect of chemokine signaling rather than a direct function of
the ligand.
action: KEEP_AS_NON_CORE
reason: >-
Actin filament organization occurs in responding cells as a consequence of
CCR3 activation by CCL11, not as a direct biochemical function of the CCL11
protein itself. This is a downstream cellular response to the chemokine signal.
- term:
id: GO:0007611
label: learning or memory
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (mouse ortholog Ccl11, P48298). Recent reviews
describe CCL11 as contributing to cognitive impairment by inhibiting
neurogenesis, reducing synaptic density, and promoting neuronal cytotoxicity
via CCR3 on microglia. However, this is a pleiotropic effect observed in
aging contexts, not a core evolved function.
action: KEEP_AS_NON_CORE
reason: >-
The link between CCL11 and learning/memory is based on aging studies in mice
where elevated blood CCL11 impairs hippocampal neurogenesis and cognition.
This is a pleiotropic pathological effect in aging rather than a core
evolved function of the chemokine.
- term:
id: GO:0035962
label: response to interleukin-13
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by
IL-13 (a type-2 cytokine) in various cell types. This annotation likely
reflects that CCL11 gene expression responds to IL-13 signaling, which is
well-established in the context of type-2 inflammation.
action: KEEP_AS_NON_CORE
reason: >-
This describes the regulation of CCL11 expression rather than a function
of the CCL11 protein. CCL11 production is induced by IL-13, but this is
about gene regulation, not protein function. Keep as non-core contextual
information.
- term:
id: GO:0045766
label: positive regulation of angiogenesis
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (mouse ortholog). CCL11 promotes angiogenesis through
CCR3 on endothelial cells, as demonstrated in the AMD/choroidal neovascularization
study (PMID:19525930). Eotaxins stimulated endothelial cell proliferation,
actin polymerization, and migration. This is a well-supported non-core function.
action: KEEP_AS_NON_CORE
reason: >-
While experimentally supported (PMID:19525930), positive regulation of
angiogenesis is a secondary/pleiotropic function of CCL11 rather than its
core evolved chemotactic function. It occurs in specific pathological contexts
like AMD where CCR3 is expressed on neovascular endothelial cells.
supported_by:
- reference_id: PMID:19525930
supporting_text: "each of the three eotaxins stimulated human CEC proliferation"
- term:
id: GO:0048245
label: eosinophil chemotaxis
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (rat ortholog). Redundant with IBA and IDA
annotations for the same term. Eosinophil chemotaxis is the core function
of CCL11.
action: ACCEPT
reason: >-
Correct core function. Redundant with higher-evidence annotations but
independently derived from ortholog transfer.
- term:
id: GO:0050768
label: negative regulation of neurogenesis
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (mouse ortholog). CCL11 has been shown to inhibit
neurogenesis in mouse aging studies. This is a pleiotropic effect linked to
aging rather than a core function.
action: KEEP_AS_NON_CORE
reason: >-
Negative regulation of neurogenesis is a secondary/aging-related effect of
CCL11 observed in mouse studies, not a core evolved function of this chemokine.
- term:
id: GO:0070371
label: ERK1 and ERK2 cascade
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (rat ortholog). CCL11 activates ERK2 and p38 MAP
kinases in eosinophils (PMID:10706854). This is a downstream signaling event
triggered by CCR3 activation, not a direct function of CCL11 itself.
action: KEEP_AS_NON_CORE
reason: >-
The ERK1/ERK2 cascade is activated downstream of CCR3 signaling upon CCL11
binding. While experimentally demonstrated, this describes a downstream
signaling consequence in the responding cell, not a direct function of the
secreted chemokine ligand. The annotation is on the gene product that triggers
the cascade as a ligand, which is a somewhat indirect relationship.
supported_by:
- reference_id: PMID:10706854
supporting_text: "Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38."
- term:
id: GO:0070670
label: response to interleukin-4
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA from Ensembl Compara (rat ortholog). CCL11 expression is induced by IL-4
signaling (via STAT6), which is well-established in the type-2 inflammation
context. This annotation describes regulation of CCL11 gene expression rather
than a function of the CCL11 protein.
action: KEEP_AS_NON_CORE
reason: >-
This describes gene regulation (CCL11 expression is induced by IL-4) rather
than a function of the CCL11 protein product. Keep as non-core contextual
information.
- term:
id: GO:0060326
label: cell chemotaxis
evidence_type: IDA
original_reference_id: PMID:33846499
review:
summary: >-
IDA annotation from PMID:33846499 (Wakabayashi et al., 2021). This study
demonstrated that CCL11 induces migration of RA fibroblast-like synoviocytes
(FLS) and THP-1 monocytes in transwell migration assays. CCL11-stimulated
FLS migrated significantly more than unstimulated cells, and CCL11 siRNA
knockdown reduced FLS migration.
action: ACCEPT
reason: >-
Cell chemotaxis is a core function of CCL11 as a chemokine. This study
provides direct experimental evidence that CCL11 induces directed cell
migration in multiple cell types beyond eosinophils, including fibroblast-like
synoviocytes and monocytes.
supported_by:
- reference_id: PMID:33846499
supporting_text: "CCL11-stimulated cells migrated significantly more efficiently than unstimulated cells (mean ± SEM, number of cells per field; 35.8 ± 5.2 and 24.5 ± 4.6, respectively, p < 0.05, Fig. 5A)"
- term:
id: GO:0070098
label: chemokine-mediated signaling pathway
evidence_type: IDA
original_reference_id: PMID:19525930
review:
summary: >-
IDA annotation from Takeda et al. (2009, Nature). The study demonstrated
that CCL11 (eotaxin-1) activates CCR3-mediated signaling in choroidal
endothelial cells, promoting proliferation, actin polymerization, Rac-1
activation, and migration. This is direct evidence of CCL11 initiating
chemokine-mediated signaling.
action: ACCEPT
reason: >-
Well-supported by experimental evidence in the Nature paper. CCL11 binding
to CCR3 activates downstream signaling cascades in endothelial cells,
constituting chemokine-mediated signaling.
supported_by:
- reference_id: PMID:19525930
supporting_text: "Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules"
- term:
id: GO:0050768
label: negative regulation of neurogenesis
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse ortholog (P48298). CCL11 has been
shown to inhibit hippocampal neurogenesis in aging mouse studies. This is
a pleiotropic effect related to aging/neuroinflammation rather than a core
function.
action: KEEP_AS_NON_CORE
reason: >-
Based on sequence similarity to mouse Ccl11 which was experimentally shown
to inhibit neurogenesis. This is a pleiotropic aging-related effect, not a
core evolved function. Redundant with IEA annotation.
- term:
id: GO:0007611
label: learning or memory
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation transferred from mouse ortholog (P48298). CCL11 affects
learning and memory in mouse aging studies. This is a pleiotropic
neuroinflammatory effect. Redundant with IEA annotation.
action: KEEP_AS_NON_CORE
reason: >-
Pleiotropic aging-related effect transferred from mouse ortholog studies.
Not a core evolved function of this chemokine.
- term:
id: GO:0046983
label: protein dimerization activity
evidence_type: IDA
original_reference_id: PMID:9712872
review:
summary: >-
IDA annotation from the NMR structural study by Crump et al. (1998). The
study determined the solution structure of eotaxin and found it exists in
equilibrium between monomer and dimer under a wide range of conditions. At
pH <= 5 and low ionic strength, eotaxin was predominantly monomeric. This
is a genuine biophysical property of the protein.
action: ACCEPT
reason: >-
Protein dimerization is an experimentally demonstrated property of CCL11.
Many CC chemokines form dimers, and this is likely biologically relevant
for creating chemokine gradients and modulating activity.
supported_by:
- reference_id: PMID:9712872
supporting_text: "The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions."
- term:
id: GO:0031728
label: CCR3 chemokine receptor binding
evidence_type: IDA
original_reference_id: PMID:11425309
review:
summary: >-
IDA annotation from the eotaxin-3 structural study. Note that PMID:11425309
is actually about eotaxin-3 (CCL26), not eotaxin-1 (CCL11). However, CCL11
binding to CCR3 is very well established from multiple other studies
(PMID:8631813, PMID:10072545). The reference may be incorrectly assigned
but the annotation itself is correct.
action: ACCEPT
reason: >-
CCR3 binding is the core molecular function of CCL11. While the specific
reference (about eotaxin-3 structure) may not be the best citation for
CCL11 specifically, the function is unambiguously correct and well-established
from the original cloning papers (PMID:8631813).
supported_by:
- reference_id: PMID:9712872
supporting_text: "The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy."
- term:
id: GO:0048018
label: receptor ligand activity
evidence_type: IDA
original_reference_id: PMID:11425309
review:
summary: >-
IDA annotation. CCL11 is a receptor ligand (for CCR3). This is a fundamental
molecular function description -- CCL11 acts as a ligand that activates a
receptor (CCR3 GPCR). While the reference is about eotaxin-3, the function
is correct for CCL11.
action: ACCEPT
reason: >-
Receptor ligand activity is a core molecular function of CCL11. It acts
as a signaling ligand for the CCR3 G-protein coupled receptor.
- term:
id: GO:0005576
label: extracellular region
evidence_type: IDA
original_reference_id: PMID:20041150
review:
summary: >-
IDA annotation with reference to PMID:20041150, a paper about MEFV gene
mutations in fibromyalgia. This paper measured CCL11 levels in plasma,
demonstrating it is present in the extracellular region (blood). The
annotation is correct for CCL11 localization.
action: ACCEPT
reason: >-
CCL11 is a secreted protein found in the extracellular region. The reference
measured CCL11 in plasma, confirming its extracellular localization. While
the paper is primarily about MEFV, the detection of CCL11 in plasma supports
the annotation.
- term:
id: GO:0007010
label: cytoskeleton organization
evidence_type: IDA
original_reference_id: PMID:10072545
review:
summary: >-
IDA annotation from Sabroe et al. (1999). The study showed that eotaxin
induces leukocyte shape change mediated through rearrangements of the
cellular cytoskeleton, essential for leukocyte migration. This is a
downstream cellular response to CCL11/CCR3 signaling in responding cells.
action: KEEP_AS_NON_CORE
reason: >-
Cytoskeleton organization in eosinophils is a downstream consequence of
CCR3 activation by CCL11, not a direct function of the CCL11 protein.
The ligand triggers cytoskeletal changes in the responding cell.
supported_by:
- reference_id: PMID:10072545
supporting_text: "Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell and are essential to the processes of leukocyte migration from the microcirculation into sites of inflammation."
- term:
id: GO:0008009
label: chemokine activity
evidence_type: IDA
original_reference_id: PMID:10072545
review:
summary: >-
IDA annotation from Sabroe et al. (1999). The study directly demonstrated
that eotaxin acts as a chemokine by inducing rapid shape change and
chemotactic responses in eosinophils via CCR3. This is direct experimental
evidence for chemokine activity.
action: ACCEPT
reason: >-
Core molecular function demonstrated by direct experimental evidence.
Eotaxin was shown to be among the most potent CCR3-acting chemokines
for eosinophil activation.
supported_by:
- reference_id: PMID:10072545
supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."
- term:
id: GO:0008360
label: regulation of cell shape
evidence_type: IDA
original_reference_id: PMID:10072545
review:
summary: >-
IDA annotation from Sabroe et al. (1999). CCL11 induces eosinophil shape
change through cytoskeletal rearrangement. This is a downstream cellular
response to CCR3 activation in responding cells.
action: KEEP_AS_NON_CORE
reason: >-
Regulation of cell shape is a downstream consequence of CCR3 signaling
in eosinophils. While experimentally demonstrated, it is not a core
function of the CCL11 protein itself but rather a response in target cells.
supported_by:
- reference_id: PMID:10072545
supporting_text: "Leukocyte shape change responses are mediated through rearrangements of the cellular cytoskeleton in a dynamic process typically resulting in a polarized cell"
- term:
id: GO:0048245
label: eosinophil chemotaxis
evidence_type: IDA
original_reference_id: PMID:10072545
review:
summary: >-
IDA annotation from Sabroe et al. (1999). Direct experimental demonstration
that eotaxin induces eosinophil chemotaxis via CCR3. This is the core
biological function of CCL11.
action: ACCEPT
reason: >-
Core function of CCL11 directly demonstrated experimentally. Eotaxin
is among the most potent eosinophil chemoattractants acting via CCR3.
supported_by:
- reference_id: PMID:10072545
supporting_text: "Those chemokines acting on CCR3 induced a rapid shape change in eosinophils from all donors; of these, eotaxin and eotaxin-2 were the most potent."
- term:
id: GO:0001938
label: positive regulation of endothelial cell proliferation
evidence_type: IDA
original_reference_id: PMID:19525930
review:
summary: >-
IDA annotation from Takeda et al. (2009, Nature). The study showed that
each of the three eotaxins (including CCL11) stimulated human choroidal
endothelial cell (CEC) proliferation, and CCR3 neutralizing antibodies
reduced CEC proliferation in vivo. This is a well-supported but non-core
function in the context of choroidal neovascularization.
action: KEEP_AS_NON_CORE
reason: >-
While experimentally well-supported in a high-impact publication, this
function is specific to the pathological context of choroidal neovascularization
in AMD, where CCR3 is aberrantly expressed on endothelial cells. It is not
the core evolved function of CCL11.
supported_by:
- reference_id: PMID:19525930
supporting_text: "each of the three eotaxins stimulated human CEC proliferation"
- term:
id: GO:0030335
label: positive regulation of cell migration
evidence_type: IDA
original_reference_id: PMID:19525930
review:
summary: >-
IDA annotation from Takeda et al. (2009). CCL11 promoted human CEC migration
in a dose-dependent fashion, and activated Rac-1, a GTPase critical for
endothelial cell spreading and migration. This reinforces the IBA annotation.
action: ACCEPT
reason: >-
Positive regulation of cell migration is a core function of CCL11 as a
chemokine. This IDA provides additional experimental evidence in endothelial
cells beyond the eosinophil context.
supported_by:
- reference_id: PMID:19525930
supporting_text: "All three eotaxins also activated Rac-1 (Supplementary Fig. S3), a small GTPase that is critical in regulating endothelial cell spreading and migration, and promoted human CEC migration in a dose-dependent fashion (Fig. 2f)."
- term:
id: GO:0030838
label: positive regulation of actin filament polymerization
evidence_type: IDA
original_reference_id: PMID:19525930
review:
summary: >-
IDA annotation from Takeda et al. (2009). Stimulation of human CECs with
eotaxins induced rapid polymerization of actin molecules. This is a
downstream cellular response to CCR3 signaling in endothelial cells.
action: KEEP_AS_NON_CORE
reason: >-
Actin polymerization is a downstream cellular response in target cells
following CCR3 activation by CCL11. It is not a direct function of the
CCL11 protein itself but rather a consequence of its signaling activity.
supported_by:
- reference_id: PMID:19525930
supporting_text: "Stimulation of human CECs with any of the three eotaxins induced a rapid polymerization of actin molecules"
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-443986
review:
summary: >-
TAS annotation from Reactome pathway "Receptor ACKR2 binds most inflammatory
CC chemokines". CCL11 is a secreted protein that binds to ACKR2 (a decoy
chemokine receptor) in the extracellular region. This is consistent with
its localization as a secreted chemokine.
action: ACCEPT
reason: >-
Correct localization for a secreted chemokine, supported by Reactome pathway
curation.
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6793978
review:
summary: >-
TAS annotation from Reactome pathway "Expression of STAT6-upregulated
extracellular proteins". CCL11 is a STAT6-induced secreted protein, consistent
with its regulation by IL-4/IL-13 signaling and extracellular localization.
action: ACCEPT
reason: >-
Correct localization. CCL11 is a STAT6-regulated secreted protein.
- term:
id: GO:0006468
label: protein phosphorylation
evidence_type: TAS
original_reference_id: PMID:10706854
review:
summary: >-
TAS annotation citing Kampen et al. (2000). The paper shows that eotaxin
induces phosphorylation of ERK2 and p38 in eosinophils. However, CCL11 is
NOT a kinase -- it is a secreted chemokine ligand. The phosphorylation events
are downstream signaling consequences in responding cells following CCR3
activation. Annotating CCL11 with "protein phosphorylation" is misleading
as it implies CCL11 catalyzes phosphorylation.
action: MODIFY
reason: >-
CCL11 is a secreted chemokine with no kinase activity. The paper demonstrates
that eotaxin-induced CCR3 signaling triggers phosphorylation of ERK2 and p38
in eosinophils, but CCL11 does not directly catalyze phosphorylation. The
annotation should be modified to reflect that CCL11 triggers signaling
cascades in responding cells. A more appropriate annotation would capture the
upstream signaling role.
proposed_replacement_terms:
- id: GO:0070098
label: chemokine-mediated signaling pathway
supported_by:
- reference_id: PMID:10706854
supporting_text: "Eotaxin (10(-11) to 10(-7) mol/L) induced concentration-dependent phosphorylation of ERK2 and p38. Phosphorylation was detectable after 30 seconds, peaked at about 1 minute, and returned to baseline after 2 to 5 minutes."
- term:
id: GO:0006874
label: intracellular calcium ion homeostasis
evidence_type: TAS
original_reference_id: PMID:10415069
review:
summary: >-
TAS annotation from Klein et al. (1999). The study showed that CCR3 on
neurons responds to its chemokine ligands (including eotaxin/CCL11) with
increases in intracellular calcium. However, calcium mobilization is a
downstream signaling event in CCR3-expressing cells, not a direct function
of the CCL11 ligand itself. Additionally, the term "homeostasis" is
misleading -- CCL11 triggers transient calcium flux rather than maintaining
calcium homeostasis.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Intracellular calcium ion homeostasis is a downstream signaling event in
CCR3-expressing cells after CCL11 binding. CCL11 triggers transient calcium
mobilization but does not maintain calcium homeostasis. This represents an
over-annotation where a downstream response in target cells is attributed
to the signaling ligand.
supported_by:
- reference_id: PMID:10415069
supporting_text: "Chemokine receptors were shown to respond to their appropriate chemokine ligands with increases in intracellular calcium that, in the case of neurons, required predepolarization with KCl."
- term:
id: GO:0006935
label: chemotaxis
evidence_type: TAS
original_reference_id: PMID:10706854
review:
summary: >-
TAS annotation from Kampen et al. (2000). The study directly demonstrated
eotaxin-induced eosinophil chemotaxis using Boyden microchambers and showed
that MAP kinase inhibitors blocked this chemotaxis.
action: ACCEPT
reason: >-
Chemotaxis is a core function of CCL11. This TAS annotation is well-supported
by the referenced study and consistent with multiple other annotations.
supported_by:
- reference_id: PMID:10706854
supporting_text: "We conclude that eotaxin induces a rapid concentration-dependent activation of ERK2 and p38 in eosinophils and that the activation of these MAP kinases is required for eotaxin-stimulated degranulation and directed locomotion."
- term:
id: GO:0006954
label: inflammatory response
evidence_type: TAS
original_reference_id: PMID:10708591
review:
summary: >-
TAS annotation from Huber et al. (2000). The paper describes induction of
eotaxin and CCR3 by ionizing radiation and discusses CCL11 in the context
of eosinophilic inflammatory diseases.
action: ACCEPT
reason: >-
Inflammatory response is a core process for CCL11. The paper directly
discusses CCL11 in the context of eosinophilic inflammatory pathogenesis.
supported_by:
- reference_id: PMID:10708591
supporting_text: "Eotaxin is an eosinophil-specific C-C chemokine that is implicated in the pathogenesis of eosinophilic inflammatory diseases, such as asthma and atopic dermatitis, by acting specifically on its receptor CCR3."
- term:
id: GO:0007155
label: cell adhesion
evidence_type: TAS
original_reference_id: PMID:10201960
review:
summary: >-
TAS annotation from Jinquan et al. (1999). The study showed that eotaxin,
in combination with IL-2 and IL-4, enhances expression of adhesion molecules
(ICAM-1, CD29, CD49a, CD49b) on T lymphocytes and promotes adhesion and
aggregation. However, the adhesion effect required prior IL-2/IL-4 stimulation
to induce CCR3 expression on T cells and is an indirect consequence of
chemokine signaling.
action: KEEP_AS_NON_CORE
reason: >-
Cell adhesion promotion by CCL11 is context-dependent (requires IL-2/IL-4
co-stimulation to induce CCR3 on T cells) and is a downstream consequence
of CCR3 signaling rather than a direct adhesion function.
supported_by:
- reference_id: PMID:10201960
supporting_text: "In combination with IL-2 and IL-4, eotaxin enhances the expression of adhesion molecules such as ICAM-1 and several integrins (CD29, CD49a, and CD49b) on T lymphocytes and thus promotes adhesion and aggregation of T lymphocytes."
- term:
id: GO:0007165
label: signal transduction
evidence_type: TAS
original_reference_id: PMID:10706854
review:
summary: >-
TAS annotation from Kampen et al. (2000). The study demonstrated that eotaxin
induces signal transduction through CCR3, activating ERK2 and p38 MAP kinases.
Signal transduction is a very broad term; more specific terms are available.
action: ACCEPT
reason: >-
While very broad, signal transduction is correct for CCL11 as a signaling
ligand that activates receptor-mediated signaling cascades. More specific
terms (chemokine-mediated signaling pathway) are also annotated.
- term:
id: GO:0009314
label: response to radiation
evidence_type: TAS
original_reference_id: PMID:10708591
review:
summary: >-
TAS annotation from Huber et al. (2000). The paper showed that CCL11 (eotaxin)
expression is upregulated by ionizing radiation in human dermal fibroblasts.
This describes the regulation of CCL11 gene expression in response to radiation,
not a function of the CCL11 protein.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This annotation describes the induction of CCL11 gene expression by ionizing
radiation, not a function of the CCL11 protein itself. The CCL11 protein does
not sense or respond to radiation; rather, its expression is upregulated by
radiation in certain cell types. This is an annotation about gene regulation
inappropriately applied to the gene product.
supported_by:
- reference_id: PMID:10708591
supporting_text: "the expression of eotaxin is upregulated upon treatment with ionizing radiation (IR) in human dermal fibroblasts"
- term:
id: GO:0009615
label: response to virus
evidence_type: TAS
original_reference_id: PMID:9558100
review:
summary: >-
TAS annotation from Rubbert et al. (1998). The paper describes CCR3 as an HIV
coreceptor on dendritic cells. CCR3 is identified as an eotaxin receptor on
dendritic cells that may be used for HIV entry. However, this paper does not
demonstrate a role for CCL11 in response to virus -- rather, it shows that
the CCL11 receptor CCR3 can be exploited by HIV for cell entry. This is an
over-annotation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The cited paper describes CCR3 (the eotaxin receptor) as an HIV coreceptor
on dendritic cells. This does not demonstrate that CCL11 protein itself
participates in response to virus. The viral exploitation of CCR3 is a
property of the receptor, not the chemokine ligand.
supported_by:
- reference_id: PMID:9558100
supporting_text: "CCR3, the eotaxin receptor, initially identified on eosinophils, is expressed on DC and may be used as an entry coreceptor by certain dual-tropic strains."
core_functions:
- molecular_function:
id: GO:0008009
label: chemokine activity
description: >-
CCL11 (Eotaxin-1) functions as a secreted CC chemokine that acts in the
extracellular space as a potent and selective chemoattractant for eosinophils.
This is its defining and canonical function. It was named "eotaxin" specifically
for this eosinophil-selective chemotactic activity. CCL11 plays a central role
in allergic/type-2 inflammatory responses by recruiting eosinophils to sites of
inflammation, and is implicated in the pathogenesis of asthma, atopic dermatitis,
eosinophilic esophagitis, and other eosinophilic inflammatory diseases.
directly_involved_in:
- id: GO:0048245
label: eosinophil chemotaxis
- id: GO:0006954
label: inflammatory response
locations:
- id: GO:0005615
label: extracellular space
- molecular_function:
id: GO:0031728
label: CCR3 chemokine receptor binding
description: >-
CCL11 binds with high affinity to CCR3, a G-protein-coupled receptor expressed
primarily on eosinophils, basophils, and certain other cell types. CCR3 binding
is the molecular mechanism by which CCL11 exerts its chemotactic and signaling
functions. Upon binding, CCR3 activates downstream signaling cascades including
calcium mobilization, ERK2/p38 MAP kinase activation, and cytoskeletal
rearrangement.
directly_involved_in:
- id: GO:0070098
label: chemokine-mediated signaling pathway
locations:
- id: GO:0005615
label: extracellular space
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:8597956
title: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.
findings:
- statement: Original cloning and functional characterization of human CCL11/eotaxin as a specific eosinophil chemoattractant.
- id: PMID:8631813
title: Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.
findings:
- statement: Identified CCR3 as the specific receptor for eotaxin/CCL11.
- id: PMID:9712872
title: Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.
findings:
- statement: Determined NMR solution structure of eotaxin showing typical chemokine fold.
- statement: Showed monomer-dimer equilibrium under a wide range of conditions.
- id: PMID:10072545
title: Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
findings:
- statement: Demonstrated eotaxin and eotaxin-2 are the most potent CCR3-acting chemokines for eosinophil shape change.
- statement: Showed CCL11 induces cytoskeletal rearrangement and shape change in eosinophils via CCR3.
- id: PMID:10201960
title: Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
findings:
- statement: Showed eotaxin can induce T cell chemotaxis and adhesion but only after IL-2/IL-4 induction of CCR3 expression.
- id: PMID:10415069
title: "Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS."
findings:
- statement: Demonstrated CCR3 on fetal neurons responds to chemokine ligands with calcium mobilization.
- id: PMID:10706854
title: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases.
findings:
- statement: Showed eotaxin induces concentration-dependent phosphorylation of ERK2 and p38 in eosinophils.
- statement: Demonstrated MAP kinase activation is required for eotaxin-induced degranulation and chemotaxis.
- id: PMID:10708591
title: Cell-type-dependent induction of eotaxin and CCR3 by ionizing radiation.
findings:
- statement: Showed eotaxin expression is upregulated by ionizing radiation in dermal fibroblasts.
- id: PMID:11425309
title: NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3.
findings:
- statement: Structural study of eotaxin-3 (CCL26), which shares CCR3 as receptor with CCL11.
- id: PMID:18275857
title: Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8.
findings:
- statement: Surveyed chemokines for DPP8 cleavage; CCL11 was not a novel DPP8 substrate.
- id: PMID:19525930
title: CCR3 is a target for age-related macular degeneration diagnosis and therapy.
findings:
- statement: Demonstrated CCL11/eotaxins promote endothelial cell proliferation, actin polymerization, and migration via CCR3.
- statement: Showed CCR3 targeting inhibits choroidal neovascularization.
- statement: Genetic ablation of Ccl11 reduced CNV in mice.
- id: PMID:20041150
title: Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels.
findings:
- statement: Measured CCL11 levels in plasma (demonstrates extracellular localization).
- id: PMID:21314817
title: "Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α."
findings:
- statement: FAP showed negligible hydrolysis of chemokines including CCL11.
- id: PMID:23597562
title: Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
findings:
- statement: IntAct interaction data for CCL11-CCR3 binding derived from this study.
- id: PMID:28381538
title: Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.
findings:
- statement: Systematic mapping of chemokine-chemokine interactions including CCL11 heteromeric interactions.
- id: PMID:33846499
title: Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis.
findings:
- statement: Demonstrated CCL11 induces migration of RA FLS and THP-1 monocytes.
- statement: Showed CCL11 siRNA knockdown reduces FLS migration.
- statement: CCL11 levels elevated in RA serum and synovial fluid.
- id: PMID:9558100
title: Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry.
findings:
- statement: Described CCR3 as HIV coreceptor on dendritic cells.
- id: Reactome:R-HSA-443986
title: Receptor ACKR2 binds most inflammatory CC chemokines
findings: []
- id: Reactome:R-HSA-6793978
title: Expression of STAT6-upregulated extracellular proteins
findings: []